---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-015624"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2024-03-27T23:59:59+00:00"
generated_at: "2026-06-04T06:59:31.559482+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Ocuphire shares investor presentation; no material new details available

## Summary
- Company furnished investor presentation under Regulation FD for March 2024 meetings.
- Exhibit 99.1 content is incomplete; no specific financial or operational updates provided.
- Presentation intended for routine investor outreach; no material changes disclosed.

## SEC filing metadata
- accession: 0001140361-24-015624
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2024-03-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036124015624/0001140361-24-015624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036124015624/ef20025199_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-015624
- JSON: https://secwatch.observer/filing/0001140361-24-015624.json
- Plain text: https://secwatch.observer/filing/0001140361-24-015624.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.